Shift Seen to Newer Agents to Treat Psoriasis
Phototherapy use for psoriasis decreased from 2005 to 2018, while use of biologics increased.
Psoriasis Information Center
Inflammation Tied to Thyroid Dysfunction With Psoriasis
Thyroid dysfunction in patients with psoriasis may be associated with inflammation caused by psoriasis.
Therapy-Switching Patterns in Children, Adolescents With Psoriasis
Many young patients with psoriasis are not receiving adequate intensive therapy to control their disease.
1990 to 2017 Saw Increase in Prevalence, Incidence of Psoriasis
From 1990 to 2017, there were increases in the global prevalence, incidence, and burden of suffering related to psoriasis.
Sex, Gender Differences in Psoriasis May Have Clinical Implications
There are sex- and gender-specific differences related to clinical characteristics and quality-of-life measures in patients with psoriasis.
Psoriasis in Adolescents Linked to Cardiometabolic Risk Factors
Early markers of cardiovascular and metabolic disease were elevated in adolescents with psoriasis, despite early disease.
Prenatal Tobacco Exposure May Increase Risk for Pediatric Psoriasis
The prenatal period is of greatest importance in tobacco’s effect on risk for pediatric psoriasis, suggesting that smoking may play a causal role in psoriasis pathogenesis, a novel study finds.
Japanese and Western Diets Contribute to Psoriasis
Surprising dietary findings show Japanese patients with psoriasis had higher BMI, lower intake of meat, and higher intake of seafood, sugar/sweeteners, vitamin D and vitamin B12, challenging long-held nutritional beliefs.
Risk for Cancer Incidence, Mortality Increased With Psoriasis
Overall cancer mortality and mortality for liver, esophageal, pancreatic cancer up with severe psoriasis.
Patients, Providers Agree on Outcome Measures for Inflammatory Skin Disorders
Patients and providers agreed that Skindex instruments are important complements to patient global assessments for determining disease burden and severity in clinical practice.
Systemic Psoriasis Therapy Linked to Higher Symtomatic UTI Risk in Women
Use of cyclosporine, infliximab, and anti-IL17 agents may be associated with increased risk of symptomatic urinary tract infection in women with psoriasis.
AAD and NPF Release Clinical Guideline on UV Therapy for Managing Psoriasis
A clinical guideline for the use of phototherapy for the care and management of adult patients with psoriasis developed by the American Academy of Dermatology (AAD) and National Psoriasis Foundation (NPF) has been published.
Biologic Treatment for Psoriasis May Reduce Coronary Inflammation
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography.
Importance of Type vs Number of Comorbidities in Psoriatic Arthritis
Type, rather than number, of comorbidities, has a greater effect on the quality of life of patients with psoriatic arthritis, according to recent research.
Psoriasis Patients Often Use Complementary, Alternative Medicine When Traditional Meds Fail
41, 39.5 percent use alternative, complementary therapies; higher use seen with severe psoriasis.
Abdominal Obesity May Raise Risk for Psoriasis
High waist circumference, regardless of overall body mass index, tied to higher risk.
Higher Risk for Mental Disorders Seen in Patients With Psoriasis
Time to onset found to be 2 to 3 months for anxiety disorders and other conditions.
Apremilast Effective for Patients Dissatisfied With Topical Corticosteroids
Addition of apremilast to a regimen of topical corticosteroids was safe and effective in patients with moderate plaque-type psoriasis.
Treatment Effect of Halobetasol Propionate/Tazarotene Combination Lotion for Plaque Psoriasis
A fixed-dose combination lotion comprised of halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) is more effective for treating moderate-to-severe plaque psoriasis than either component alone.
Halobetasol Propionate/Tazarotene Combination Lotion May Offer Sustained Symptomatic Relief in Plaque Psoriasis
Researchers completed 2 post hoc analyses of large, double-blind trials examining the efficacy of HP/TAZ combination therapy for clinically meaningful outcomes.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Psoriasis Information Center
